Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
July 3, 2008

PerkinElmer Creates Center to Advance Cord Blood Stem Cell Studies

  • PerkinElmer has established the ViaCord Research Institute™ (VRI™) to focus on investigating potential uses of umbilical cord blood-derived stem cells.

    VRI will concentrate on supporting science, technology, and medical treatments using cord blood stem cells in five key areas: cord blood technologies, emerging stem cell therapies, genetic screening, product development and related transplants.

    The institute will be led by a team of scientists and physicians including leading experts in the areas of stem cell biology, maternal-fetal medicine, obstetrics and gynecology, transplant medicine, and genetics.

    Cord blood is a noncontroversial source of stem cells with proven effect in treating more than 70 serious diseases including many cancers and immunodeficiencies, according to the PerkinElmer.

  • You’re all set! Thank you for subscribing to GEN Highlights.